METHYL-5-ACETAMIDO-4-C-ACETOXYMETHYL-7,8,9-TRI-O-ACETYL-2,6-ANHYDRO-3,5-DIDEOXY-D-GLYCERO-D-TALO-NON-2-ENONATE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 53sSsrAPEAm |
|---|---|
| InChI | InChI=1S/C21H29NO13/c1-10(23)22-19-18(17(34-14(5)27)16(33-13(4)26)8-31-11(2)24)35-15(20(28)30-6)7-21(19,29)9-32-12(3)25/h7,16-19,29H,8-9H2,1-6H3,(H,22,23)/t16-,17+,18-,19-,21-/m1/s1 |
| InChIKey | KEWFXICYDZKOSP-TWHPPBISSA-N |
| Mol Weight | 503.46 g/mol |
| Molecular Formula | C21H29NO13 |
| Exact Mass | 503.16389 g/mol |
| Enantiomer InChIKey | KEWFXICYDZKOSP-RVDAZCDBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
METHYL-5-ACETAMIDO-7,8,9-TRI-O-ACETYL-2,6-ANHYDRO-3,5-DIDEOXY-4-C-METHOXYMETHYL-D-GLYCERO-D-TALO-NON-2-ENONATE
METHYL-5-ACETAMIDO-4,7,8,9-TETRA-O-ACETYL-3,5-DIDEOXY-3-FLUORO-D-ERYTHRO-ALPHA-L-MANNO-2-NONULOPYRANULOSATE
No Name
DIETHYL-(METHYL-4,7,8,9-TETRA-O-ACETYL-5-TERT.-BUTOXYCARBONYLAMINO-3,5-DIDEOXY-D-GLYCERO-BETA-D-GALACTO-2-NONULOPYRANOSYLONATE)-PHOSPHITE
METHYL-4,7,8,9-TETRA-O-ACETYL-2,6-ANHYDRO-3,5-DIDEOXY-5-(2,2,3,3,4,4,4-HEPTAFLUOROBUTNAMIDO)-D-GLYCERO-D-TALO-NON-2-ENONATE
TEHRANOLIDE
#7;ALLYL-3,6-DI-O-BENZOYL-4-O-(2-O-BENZOYL-4,6-DI-O-BENZYLIDENE-3-O-CHLOROACETYL-BETA-D-GALACTOPYRANOSYL)-2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSIDE
6,9-EPI-8-O-ACETYL-SHANZHISIDE-METHYLESTER
6-EPI-BARLERIN
(1R,2S,3R,4S,5R,6R)-5-Acetamido-1-(acetoxymethyl)-7-oxabicyclo[4.1.0] heptane-2,3,4-triyl triacetate
| Title | Journal or Book | Year |
|---|---|---|
| A facile synthesis of Neu5Ac2en derivatives from the glycosides of N-acetylneuraminic acid | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.